Login
Password
Remember Me
Clean Cells et Xenothera, deux acteurs d’Atlanpole Biothérapies dans la lutte contre le SARS-COV-2 La CDMO vendéenne Clean Cells a mis...
G&CTI, premier think tank indépendant sur les thérapies avancées Dans l’environnement actuel où les thérapies géniques et cellulaires apparaissent certes comme...
Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics Agilent Technologies will expand its state-of-the-art production facility in Frederick, Colorado,...
More articles from NEWS
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
BioPharmAnalyses and OctopusyX BioConsulting are proud to announce the launch of their up-dated and enriched 2019 edition of their report...
300 million people living with a rare disease worldwide An open-access article, written by Orphanet (coordinated by INSERM, the French National...
More articles from ANALYSES
An artificial intelligence approach to create AAV capsids for gene therapies Adeno-associated viruses (AAVs) have become the go-to vehicle for delivering...
Transforming DNA repair errors into assets A new bioinformatics tool, MHcut, developed by researchers in Kyoto, Japan, and Montreal, Canada, reveals that...
Accumulation of DNA mutations found in healthy liver leads to disease New insights into the journey from health to disease in...
More articles from SCIENTIFIC NEWS
